Latest Scleroderma Stories

SAN JOSE, Calif., Dec. 4 /PRNewswire-USNewswire/ -- Music and civil rights icon Odetta succumbed December 2 as a result of multiple illnesses. One of them was pulmonary fibrosis (PF), an illness that relentlessly fills the lungs with scar tissue and suffocates its victims, and is one of the deadliest yet least well known diseases in the country. Despite being diagnosed with PF two years ago, a diagnosis that was essentially a death sentence, Odetta went on to perform extraordinary concerts...

DANVERS, Mass., Oct. 24 /PRNewswire/ -- The Scleroderma Foundation, in conjunction with leading rheumatologists and pulmonary hypertension specialists, today announced the launch of the ECHO educational campaign to raise awareness of the increased risk of developing pulmonary arterial hypertension (PAH) among scleroderma patients, and to encourage healthcare professionals to conduct annual echocardiograms to ensure that PAH is diagnosed and treated early. PAH is a rare, life-threatening...

By Jonathan Devin Antonella Ferreira of Southaven is a typical 11-year-old in many ways. She enjoys drawing, helps her schoolmates with Spanish words and likes to swim. But unlike other children her age, Ferreira faces daily challenges from a chronic condition, which she courageously fights by lending her own face to the cause. Ferreira's disability, scleroderma, includes physical debilitation on the right side of her body. Her right leg is 6 inches shorter than the other, and two fingers...

GeneraMedix has received approval from the FDA for its Epoprostenol for Injection 1.5mg new drug application. GeneraMedix's Epoprostenol for Injection 1.5mg is indicated for the long-term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA Class III and Class IV patients who do not respond adequately to conventional therapy. Ronald Quadrel, president and CEO of GeneraMedix, said: "The addition of...

arGentis Pharmaceuticals, LLC announced today that the Phase II results using highly purified type 1 bovine collagen orally (now known as ARG201) in the treatment of diffuse cutaneous systemic sclerosis (scleroderma - SSc) have been published in the June issue of Arthritis & Rheumatism, a major peer-reviewed rheumatology research journal. Systemic sclerosis is an autoimmune disease causing widespread fibrosis of the skin and internal organs. ARG201 is an immunotherapy that induces low dose...

By Babin, Lynn A Dermatology Nursing Essentials: A Core Curriculum (2nd edition) was written to provde the reader with core knowledge about the specialty of dermatology nursing. Key points from the text are highlighted to test and review your dermatology nursing knowledge. These quick hits of information are no substitute for the indepth analysis provided in the Core Curriculum, but are designed to whet your appetite for the comprehensive content that the Core delivers. References for the...

By Park, Joo Hun; Kim, Dong Soon; Park, I-Nae; Jang, Se Jin; Et al Background: To investigate whether the better prognosis of interstitial pneumonias associated with collagen vascular disease (CVD) compared with idiopathic interstitial pneumonia (IIP) is due to higher frequency of the nonspecific interstitial pneumonia (NSIP) pattern in CVD, we compared the outcomes of patients from these two groups with the same histopathologic pattern. Subjects: The clinical features and survival of 362...

Scleroderma's symptoms can range from hardened skin to damaged internal organsIt's called scleroderma, a disfiguring disorder that causes the skin and internal organs to harden and tighten.Yet few people have heard of or know much about it.But that's not surprising, because medical experts have great gaps in their knowledge of the disease. There's no known cure for scleroderma, and although it's suspected to be an autoimmune disorder, doctors still debate its true cause.But experts agree on...

ABSTRACT: The purpose of this study was to identify hand factors that change over a five-year period that may be risk factors for the development of functional disability in persons with systemic sclerosis (scleroderma). Sixty individuals with scleroderma were administered assessments of grip and pinch strength, joint range of motion, and pain, and were observed for the presence of digital ulcers, digital scars, calcium deposits, puffy fingers, and tendon friction rubs. Matched-pairs chi...